Search Results: test Naming

FDA Releases Biosimilar Naming Guidance

FDA just released a final Guidance for Industry, “Nonproprietary Naming of Biological Products.”  The guidance provides that naming for originator biological products, related biological products, and biosimilars should include a “core name” followed by a four-letter suffix.  The core name typically will be the USAN Council name for the Reference Product (RP)….

Read More

Survey Suggests Pharmacists Prefer Non-Proprietary Proper Names for Biosimilars

The August, 2016, edition of the Journal of Managed Care & Specialty Pharmacy published the results of a survey designed to measure pharmacists’ view on biosimilar naming conventions.  (See our previous posts here and here for more information regarding the naming of biosimilars.)  The survey found that pharmacists would generally prefer…

Read More